For the Press

New Editor-in-Chief for Annals of Surgical Oncology Announced

Author: SSO Staff
Date:
Oct 30, 2017

The Society of Surgical Oncology Announces New Editor-in-Chief for Annals of Surgical Oncology

kelly-mcmastersThe Society of Surgical Oncology announces Kelly M. McMasters, MD, PhD as the new Editor-in-Chief of Annals of Surgical Oncology (ASO) effective March 2018. Dr. McMasters becomes only the second Editor in the journal’s nearly 25-year history to assume the role. He will oversee the print and online editions of ASO and with Mark Roh, MD, Executive Editor, will lead a prestigious editor roster of expert leaders in surgical oncology, including more than 20 section editors and associate section editors from around the world, as well as U.S.-based associate and deputy editors. Dr. McMasters begins his position on March 23, 2018 in conjunction with the journal’s 25th anniversary and the retirement of Charles M. Balch, MD, who established the prominence of the publication in the field of surgical oncology. Dr. McMasters will report directly to the SSO Executive Council and will carry out editorial responsibilities from his office in Louisville, KY. SSO President-Elect Armando E. Giuliano, MD, FACS said, “I am very pleased to confirm the appointment of Dr. Kelly McMasters by the SSO Executive Council as the Editor-in-Chief for Annals of Surgical Oncology. Dr. McMasters has demonstrated extraordinary leadership, scholarship and commitment to the SSO and the Annals of Surgical Oncology. His tenure and contributions as a Deputy Editor for the journal makes him an excellent choice to develop and implement a strategic vision for the future of the publication.”

Dr. McMasters is the Ben A. Reid, Sr., MD, Professor and Chair of the Hiram C. Polk, Jr., MD Department of Surgery at the University of Louisville School of Medicine, where he also serves as Director of the Multidisciplinary Melanoma Clinic and Associate Director of the James Graham Brown Cancer Center. His laboratory has focused on cancer gene therapy and melanoma biomarkers and has been funded by the American Cancer Society, the National Institutes of Health, and the Melanoma Research Foundation, among other agencies. He holds two patents for his research inventions. He is the author and Principal Investigator of the Sunbelt Melanoma Trial, a multi-institutional study involving more than 3,500 patients from 79 institutions across North America. Dr. McMasters is President of the Society of Surgical Oncology, President of the Western Surgical Association, President of the Society of Surgical Chairs, Secretary of the Southern Surgical Association, and past President of the Southeastern Surgical Congress. He served on the Melanoma Staging Committee of the American Joint Commission on Cancer (AJCC) and has served as a Deputy Editor of Annals of Surgical Oncology since February 2016. He has published over 400 articles in the medical/scientific literature, as well as 19 book chapters.  He is co-editor of the book: Hepatocellular Carcinoma. Targeted Therapy and Multidisciplinary Care. He earned his medical degree at UMDNJ-Robert Wood Johnson Medical School and his PhD in Cell and Developmental Biology from Rutgers University. He completed his General Surgery residency at the University of Louisville School of Medicine and his fellowship in Surgical Oncology at the University of Texas MD Anderson Cancer Center in Houston.

Annals of Surgical Oncology has a rich heritage as the premier source of clinical and translational science related to cancer surgery and multidisciplinary care. It is an honor and a privilege to lead an outstanding editorial board into the future,” said Dr. McMasters.

ASO is the worldwide journal of choice of surgical oncologists and is the official journal of the Society of Surgical Oncology and the American Society of Breast Surgeons. According to Thompson-Reuters, in the 2016 impact factor ranking among all surgical oncology scholarly periodicals, ASO has the most citations of all surgical journals in the world, the highest number of source items, and a current impact factor of 4.041. The journal promotes clinical and translational cancer research, with an emphasis on clinical trials. Leading subject areas of ASO include Gastrointestinal Oncology, Breast Oncology, Hepatobiliary Tumors, Colorectal Cancer, Thoracic Oncology, and Translational Research. ASO strives to enhance the quality of life and survival of the surgical patient with cancer and to improve the practice environment in which high-quality surgical oncology care is delivered. ASO also facilitates the career development of surgical trainees and their transition into academic and community-based practice and publishes timely articles about public policy and patient advocacy issues related to the surgical patient with cancer.

About the Society of Surgical Oncology
The Society of Surgical Oncology (SSO) is the premier international organization for surgeons and health care providers dedicated to advancing and promoting the science and treatment of cancer. The Society’s focus on all solid-tumor disease sites is reflected in its Annual Cancer Symposium, monthly scientific journal (Annals of Surgical Oncology), educational initiatives and committee structure. The Society’s mission is to improve multidisciplinary patient care by advancing the science, education and practice of cancer surgery worldwide